FDA
Breakthrough Device Designation
- Granted March 2026
Catheter-Grade Non Invasive Heart Failure Management
Coredio measures intra-cardiac metrics using wearables, AI, and digital twins
The Challenge
Current cardiac monitoring is fragmented, slow, and invasive.
Inefficient Monitoring
BP cuffs and weight scales often provide inaccurate or late indications of heart failure escalation.
Invasive Procedure Burden
Clinicians use 5+ platforms to view patient data
Time-Consuming Monitoring
Clinicians use 5+ platforms to view patient data
Fragmented Data Systems
Clinicians use 5+ platforms to view patient data
Invasive Procedure Burden
Clinicians use 5+ platforms to view patient data
Time-Consuming Monitoring
Clinicians use 5+ platforms to view patient data
Fragmented Data Systems
Clinicians use 5+ platforms to view patient data
Invasive Procedure Burden
Clinicians use 5+ platforms to view patient data
Time-Consuming Monitoring
Clinicians use 5+ platforms to view patient data
The Challenge
Current cardiac monitoring is fragmented, slow, and invasive.
Inefficient Monitoring
Clinicians use 5+ platforms to view patient data
Limited Accessibility
Catheterization is the gold standard but carries high costs ($5k-$10k)
Invasive & Costly Care
Stable patients require expensive, frequent in-hospital echocardiograms.
Fragmented Data Systems
Clinicians use 5+ platforms to view patient data
Invasive Procedure Burden
Clinicians use 5+ platforms to view patient data
Time-Consuming Monitoring
Clinicians use 5+ platforms to view patient data
Fragmented Data Systems
Clinicians use 5+ platforms to view patient data
Invasive Procedure Burden
Clinicians use 5+ platforms to view patient data
Time-Consuming Monitoring
Clinicians use 5+ platforms to view patient data